Skip to content

Sorgem Evaluation was commissioned to model the risk analysis calculations carried out by Euronext

Sorgem Evaluation was commissioned to model the risk analysis calculations carried out by Euronext

Sorgem Evaluation recently assisted a client who, as part of its derivatives business, needed to switch to the Euronext clearing platform. The challenge was that, although Euronext provided the necessary margin calls, the details of the calculations were not disclosed.

To ensure that the margin calls met its clients’ expectations, the company asked us to develop a tool capable of replicating the risk analysis calculations carried out by Euronext. To achieve this, we undertook the following work:

  1. Methodological review: We analysed the calculation methodology of the Euronext clearing platform based on the documentation provided;
  2. Tool development: We developed an SQL script to replicate the risk analysis calculations based on Monte Carlo simulations;
  3. Validation of results: We compared the results obtained with those provided by Euronext to ensure that the model was correctly calibrated.

Thanks to this approach, our client now has a robust in-house tool enabling it to validate and monitor margin calls with complete transparency and accuracy.

Article précédent Article suivant

Ces articles pourraient vous intéresser

Actualités

Proposed public buy-out offer by the SMABTP Group – Appointment of Sorgem Evaluation

Proposed public withdrawal offer by the SMABTP Group for Société de la Tour Eiffel at a price of 8.20 euros

2 April 2026

Lire

Actualités

Unfair competition: Judgment of the Paris Court of Appeal in the dispute between Tediber and Emma

In its judgement of 2 April 2025 (Case No. RG 23/05696), the Paris Court of Appeal held that EMMA was

10 April 2025

Lire

Actualités

Sorgem Évaluation was involved in the evaluation of predictive medicine software with a view to its planned commercialisation through a licensing arrangement

MammoRisk® is the first solution developed by Predilife, designed for stratified breast cancer screening. This software is based on a

25 November 2024

Lire

Have a question or a need?

contact us